Development and Validation of a Mathematical Model to Describe Anti-Cancer Prodrug Activation by Antibody-Enzyme Conjugates

From MaRDI portal

Revision as of 06:46, 7 February 2024 by Import240129110113 (talk | contribs) (Created automatically from import240129110113)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Publication:4485160

Jump to:navigation, search

DOI10.1080/10273660008833040zbMath0965.92024OpenAlexW2023493258MaRDI QIDQ4485160

Peter D. Senter, James D. Murray, Trachette L. Jackson

Publication date: 7 August 2001

Published in: Journal of Theoretical Medicine (Search for Journal in Brave)

Full work available at URL: https://eudml.org/doc/230063

zbMATH Keywords

ordinary differential equations partial differential equations cancer chemotherapy tumor heterogeneity antibody-enzyme conjugates prodrugs

Mathematics Subject Classification ID

Kinetics in biochemical problems (pharmacokinetics, enzyme kinetics, etc.) (92C45) Medical applications (general) (92C50)

Related Items (3)

Intracellular accumulation and mechanism of action of doxorubicin in a spatio-temporal tumor model ⋮ Mathematical modelling of the use of macrophages as vehicles for drug delivery to hypoxic tumour sites ⋮ A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy

This page was built for publication: Development and Validation of a Mathematical Model to Describe Anti-Cancer Prodrug Activation by Antibody-Enzyme Conjugates

Retrieved from "https://portal.mardi4nfdi.de/w/index.php?title=Publication:4485160&oldid=18561145"